AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $42.16
- 52-wk high
- $45.42
- High
- $42.16
- 52-wk low
- $14.47
- Low
- $40.82
- Prev close
- $41.82
Smart money
Earnings
Earnings came in 13.6% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $7.1M |
| Cost of what it sold | $105.0K | $101.0K | — | — |
| Gross profit | -$105.0K | -$101.0K | — | $7.1M |
| What it spent | ||||
| Research and development | $114.2M | $98.9M | $142.3M | $142.6M |
| Sales and admin | $17.5M | $15.4M | $17.3M | $17.7M |
| Total operating expenses | $131.8M | $114.4M | $159.6M | $160.3M |
| What was left | ||||
| Operating profit | -$131.8M | -$114.4M | -$159.6M | -$153.2M |
| Profit before tax | -$125.9M | -$109.1M | -$150.7M | -$153.2M |
| Tax | $594.0K | $1.6M | -$2.8M | — |
| Net profit | -$126.5M | -$110.6M | -$147.9M | -$153.2M |
| EBITDA | -$125.8M | -$109.0M | -$150.6M | -$153.1M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
60balanced
20D volatility
28%annualized
52-week range
$14.47$45.42
20D support
News
What the news says
17 articles · 7 days
Coverage is mixed
Tone of tracked coverage
GSA Capital Partners LLP Takes $2.52 Million Position in Immunovant, Inc. $IMVT
Leans bullishAug 16Assenagon Asset Management S.A. Has $639,000 Holdings in Immunovant, Inc. $IMVT
NeutralAug 16Dimensional Fund Advisors LP Sells 103,356 Shares of Immunovant, Inc. $IMVT
Leans bearishAug 15
